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Abstract Nramp1 (natural resistance-associated macrophage
protein) controls innate immunity and encodes a transporter of
unknown function. Here we describe an antibody to Nramp1
displaying immunoreactivity towards a mature heavily glycosyl-
ated polypeptide of 90^100 kDa and a precursor form of 45 kDa
in macrophages. Ectopic expression of the Nramp1 cDNA in
COS-1 cells demonstrates that Nramp1 modulates cellular iron
levels following loading with low molecular weight iron chelates.
Surprisingly, Nramp1 does not enhance iron uptake, but
expression is associated with reduced cellular iron loads. We
propose Nramp1 may play a role in a salvage pathway of iron
recycling.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Natural resistance or susceptibility to infection toward a
number of unrelated intracellular pathogens is controlled by
the Ity/Lsh/Bcg locus on mouse chromosome 1 (see [1,2] for
review). Experiments by Gros and colleagues, using mouse
gene knockout [3] and transgenic [4] techniques, have con-
¢rmed that this phenotype is controlled by a single gene,
namely Nramp1 (Natural resistance-associated macrophage
protein). Murine Nramp1 encodes a polytopic integral mem-
brane protein, with two consensus sites for N-linked glycosyl-
ation and an amino-terminal proline-rich sequence [5]. A se-
quence motif in one of the intracellular loops has been
described as a consensus transport signature [6]. This latter
observation, together with recent work on other members of
the highly conserved Nramp gene family support the hypoth-
esis that Nramp1 encodes a transporter molecule. Nramp2
(78% identity to Nramp1 in mouse) transports a number of
metal ions when expressed in frog oocytes [7]. Innate resist-
ance or susceptibility to infection in mouse has been invaria-
bly associated with a single G169D amino acid substitution
within transmembrane region 4 of the Nramp1 polypeptide
sequence [8]. Such a change in a hydrophobic environment
could be envisioned to have a deleterious e¡ect on the puta-
tive transport function of Nramp1. Moreover, Nramp1 gene
knockout experiments demonstrated the Nramp1D169 allele is
functionally indistinguishable from the null mutant [3].
The Nramp1 polypeptide has been localised to intracellular
vesicular membranes in resting cells, and co-puri¢es with bead
containing phagosomes after challenge with IgG-coated latex
beads [9,10]. Such a localisation suggested that Nramp1 could
in£uence the micro-environment of the invading pathogen
within the phagolysosome by either directing the e¥ux or
in£ux of some essential substrate or toxin respectively. Recent
data have established that the Nramp-related yeast genes,
SMF1 and SMF2 encode high and low a⁄nity manganese
transporters respectively [11]. Supek and co-workers [11] pro-
posed that Nramp1 may blunt a key defence mechanism of
many micro-organisms by depleting the phagosomal lumen of
Mn2. Depletion of the phagosome of divalent manganese
would prevent the engulfed microbes from biosynthesising
active defense enzymes such as manganese-dependent super-
oxide dismutase. It is likely that Nramp1 exhibits di¡erent
transport properties to Nramp2, since the double SMF1/2
knockout yeast strain associated with hypersensitivity to
EGTA and growth at alkaline pH could be complemented
by Nramp2 [12], but not Nramp1. Rodent Nramp2 trans-
ported not only Mn2, but a variety of other divalent metal
cations, into Nramp2 transfected Xenopus oocytes [7] includ-
ing high a⁄nity ferrous iron (Fe2) transport. This result is of
particular relevance in light of a recent study where a candi-
date iron transporter gene, identi¢ed as Nramp2, was respon-
sible for murine microcytic anaemia associated with a defect
in intestinal iron uptake [13].
To investigate Nramp1 structure and function, we have
generated an Nramp1-speci¢c antiserum, and developed a
model expression system for analysis of Nramp1 function.
These ¢ndings demonstrate that the Nramp1 polypeptide ex-
ists in two forms dependent upon the level of protein glyco-
sylation. Ectopic expression of the heavily glycosylated
Nramp1 polypeptide in COS-1 cells modulated iron levels.
This important ¢nding has implications for how Nramp1
may confer resistance to microbial infection in vivo and the
role of the protein in macrophage function.
2. Materials and methods
2.1. Preparation of Nramp1 expression constructs and antisera
Anti-Nramp1 antibody was prepared against recombinant fusion
protein using the pGEX1 expression vector [14] corresponding to
amino acids 1^82 of the Nramp1 sequence by routine PCR cloning
techniques. Recombinant clones were characterised by DNA sequenc-
ing. Antisera were raised against the fusion protein (0.5 mg per rabbit
per injection), emulsi¢ed in Freund’s complete or incomplete adju-
vant, in New Zealand white rabbits by intramuscular injection.
2.2. A⁄nity puri¢cation of the anti-Nramp1 immunoreactive serum
Puri¢cation was performed by passage of the serum down an im-
mobilised MBPp (maltose binding protein) Nramp1 A⁄-gel 15 col-
umn (1 ml) as described [9]. MBPpNramp1 plasmid was prepared as
above for pGEXNramp1. The recombinant protein was a⁄nity puri-
¢ed on amylose resin (NEB) as described by the manufacturers.
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2.3. Cell culture and transient transfection
Cells used were the well characterised microglial cells N11 [15] and
the COS-1 cell. N11 cells were plated onto tissue grade plates and
treated with murine Q-IFN (10 units/ml) (Gentech) or with lipopoly-
saccharide (LPS, Sigma) (100 ng/ml) alone or in combination. Protein
concentrations of cell extracts were determined using the BCA proto-
col (Pierce). Routinely 20 Wg of total cell protein was loaded on a
single track for SDS-PAGE. Immunoblotting was performed by
standard procedures and detection was by HRP conjugated goat
anti-rabbit secondary antibody. Blots were visualised by chemilumi-
nescence (ECL, Amersham). Transient transfection into COS-1 cells
was performed using lipofectamine (BRL) according to the manufac-
turer’s instructions with a pcDNA3 Nramp1glyÿ169 allele expression
plasmid and a derivative containing a large T epitope tag at the C-
terminus. Cells were harvested 48 h post-transfection as above for
Western analysis or used in iron uptake experiments.
2.4. Treatment of N11 cell extracts with glycosidases
Extracts were prepared in 0.5% SDS containing L-mercaptoethanol
(1%) either by boiling samples (20 Wg) or by syringe lysis. Samples
were treated with 1000 units PNGase F (BRL) according to the manu-
facturer’s instructions and at room temperature overnight.
2.5. Iron uptake and ferrozine assay
To prepare the low molecular weight iron chelate Fe:NTA (nitrilo-
triacetate), FeCl3 was dissolved in HCl and added to aqueous NTA in
a 1:1 molar ratio. Transfected COS-1 cells were extensively washed in
RPMI medium alone to remove serum and then incubated in RPMI
medium containing 50 WM Fe:NTA for 4 h at 37‡C. Plates were
placed on ice, medium removed and the cells washed three times in
ice-cold PBS, containing 5 mM EDTA (pH 7.4). Cell monolayers were
harvested in PBS/5 mM EDTA and by scraping. Cells were trans-
ferred into a microfuge tube and washed a further two times in
PBS alone. Aliquots were removed for protein determination (BCA,
Pierce) and iron determination. Cellular iron levels were measured as
described [16]. Brie£y, washed cells were resuspended in distilled
water, transferred to glass hydrolysis tubes to which an equal volume
of HNO3 (6 M) was added. Extracts were incubated for 18 h at 100‡C
to release total cell-associated iron. Iron levels were assayed using the
ferrozine method [17], except that the ammonium acetate bu¡er was
made to 15% (w/v) containing NaOH (3.2 M).
3. Results
3.1. Nramp1 reactive antiserum
To facilitate the study of Nramp1 an N-terminal reactive
polyclonal antiserum was generated which was subjected to
a⁄nity puri¢cation, and designated B1-NT. The reactivity of
B1-NT against the native Nramp1 polypeptide was con¢rmed
by Western blotting of COS-1 cell extracts from cells transi-
ently transfected with the plasmid pCDNA3 containing the
full length Nramp1 sequence (Fig. 1a and b). The Nramp1
expression construct was engineered with a carboxy-terminal
located large T epitope tag which is recognised by the mono-
clonal antibody KT3 [18]. Western blots of control extracts;
and either mock transfectants or transfection with a
pCDNA3/iNos (inducible nitric oxide synthase) construct,
failed to demonstrate reactivity against B1-NT (Fig. 1a, lanes
1 and 3). Blotting COS-1 cells transfected with the epitope
tagged Nramp1 expression plasmid yielded B1-NT reactive
bands clustered around 90^100 kDa and 45 kDa (Fig. 1a,
lane 2). Probing an identical blot with the anti-large T anti-
serum KT3 revealed a similar pattern to B1-NT (Fig. 1b) and
con¢rmed that B1-NT does cross-react with native Nramp1.
The endogenous large T antigen in COS-1 cells, migrating at
about 95 kDa in SDS-polyacrylamide gels, is recognised by
KT3 (Fig. 1b).
Antiserum B1-NT was employed to examine endogenous
Nramp1 expression in the murine microglial cell line, N11
[9,15]. This cell line carries the resistant wild-type
(Nramp1G169) allele of Nramp1 (Atkinson and Barton unpub-
lished). Nramp1 expression in these cells is constitutive, with
little modulation upon cell stimulation with either Q-interferon
(Q-IFN), lipopolysaccharide (LPS), or both. The general pat-
tern of immunoreactivity, bands at 90^100 kDa and to a lesser
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Fig. 1. Immune-detection of Nramp1 polypeptide in mammalian
cells. a, b: Following transient expression of ectopic Nramp1 cDNA
in COS-1 cells. COS-1 cells were mock transfected (lane 1), trans-
fected with pcDNA3 plasmid DNA incorporating the full length
Nramp1 cDNA (lane 2) corresponding to the G169 allele and a C-
terminal located large T antigen epitope tag, or with pcDNA3 in-
corporating the murine iNos cDNA (lane 3) and using lipofectamine
(BRL). 48 h post-transfection whole cell extracts were prepared and
Nramp1 expression analysed from 20 Wg samples using (a) the anti-
N-terminal reactive Nramp1 B1-NT antisera or (b) the KT3 mouse
monoclonal antibody and by Western blotting. Positions of 45 kDa
and 90^100 kDa polypeptides are indicated of the left. c : Native
Nramp1 polypeptide in N11 microglial, macrophage lineage cells.
N11 (Nramp1 G169 allele) cell extracts (20 Wg) were analysed for
anti-Nramp1 reactivity using the N-terminal antibody. Extracts were
prepared in SDS-PAGE Laemmli sample by cell lysis using a gauge
23 syringe (lanes 1^4) or by boiling (lanes 5^8). Cells were untreated
(lanes 1 and 5), treated overnight with Q-IFN (10 U/ml) (lanes 2
and 6), with lipopolysaccharide (100 ng/ml) (lanes 3 and 7) or with
lipopolysaccharide and Q-IFN (lanes 4 and 8). Positions of 45 kDa
and 90^100 kDa proteins are indicated of the left. d: 45 kDa is the
precursor for the glycosylated 90^100 kDa Nramp1 protein. Whole
cell extracts from untreated N11 cells were prepared in SDS and L-
mercaptoethanol as above by boiling (lanes 1 and 3) or by syringe
lysis (lanes 2 and 4). 20 Wg aliquots of protein were incubated with
PNGase F and analysed by Western blotting using the N-terminal
anti-Nramp1 antisera. Samples were not reboiled subsequent to
SDS-PAGE. Positions of 45 kDa and 90^100 kDa polypeptides are
indicated on the left.
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extent 45 kDa, was similar to Nramp1 transfected COS-1 cells
(Fig. 1c, lanes 1^4). The fainter 45 kDa bands were not seen
in every N11 Western blot; this variability between blots may
well be the result of di¡erences in the glycosylation status of
Nramp1 (see below). In the above experiments, N11 extracts
were prepared in Laemmli sample bu¡er prior to SDS-PAGE,
but without the standard boiling procedure. Boiling of sam-
ples led to a loss of immunoreactive protein from the resolv-
ing gel (Fig. 1c, lanes 5^8). This was probably due to protein
aggregation as high molecular weight material was often
trapped in the sample wells. Similar ¢ndings have been re-
ported by others [19]. Western blotting of N11 extracts with
B1-NT antiserum revealed a Q-IFN induced 50 kDa protein
that migrated more slowly than the Nramp1 45 kDa proteins
(Fig. 1c, lanes 2 and 4). This protein was una¡ected by heat
treatment (Fig. 1c, lanes 6 and 8). The identity of this band is
unclear, but it may be a product of the murine Nramp2 gene
as there is some sequence similarity between the two Nramp
proteins over the ¢rst 82 residues. Expression of this polypep-
tide in ¢broblast cells NIH 3T3 (Atkinson and Barton unpub-
lished) excludes it from being derived from the Nramp1 gene
as the latter cells do not express the appropriate mRNA [6].
Glycosidase PNGase F treatment of N11 extracts demon-
strated that the Nramp1 protein is heavily glycosylated in this
cell line (Fig. 1d). Exhaustive PNGase F digestion caused the
disappearance of the 90^100 kDa bands with the concomitant
strong appearance of the 45 kDa immunoreactive bands (Fig.
1d, lanes 2 and 4). These results strongly suggest that the 90^
100 kDa Nramp1 protein is the mature, fully glycosylated
protein, whereas the 45 kDa polypeptides represent partially
or non-glycosylated precursor forms. Samples that were
boiled prior to glycosidase digestion failed to migrate into
the resolving gel. This suggests that the boiling treatment
either prevents access of the PNGase F to the appropriate
glycosylation sites or that the aglycosyl form of the protein
remains aggregated (Fig. 1d, lanes 1 and 3).
3.2. Nramp1 and iron levels in COS-1 cells
The transport activity of Nramp1 was investigated in the
previously developed COS-1 cell Nramp1 transient transfec-
tion system. Iron delivery to cells was provided by complexing
iron with the low molecular weight chelate, NTA, since cells
readily take up iron in this form [20]. COS-1 cells were trans-
fected as above. 48 h post-transfection, cells were incubated in
50 WM Fe3 :NTA in the absence of serum. Iron uptake was
for 4 h at 37‡C prior to cell harvesting. In three independent
experiments (Fig. 2), successful Nramp1 protein expression
was con¢rmed by Western blotting with antiserum B1-NT
(Fig. 2a). Similar Nramp1 protein expression, as determined
by the degree of staining on the Western blot, was evident in
all three experiments (Fig. 2a, lanes 1, 3 and 5). Extracts from
cells transfected with vector alone failed to show any reactiv-
ity towards B1-NT (Fig. 2a, lanes 2, 4 and 6).
Iron incorporation using the ferrozine assay demonstrated a
net accumulation of iron into the cells whilst COS-1 cells
incubated in serum-free media alone, or in the presence of
50 WM NTA did not contain measurable cellular iron as as-
sayed by this method (data not shown). In the presence of
extracellular iron Nramp1 transfected cells were associated
with lower net iron levels when compared to the experimental
controls. These reductions ranged from 24^55% and averaged
39% over the three experiments (Fig. 2b). Net iron accumu-
lation over the 4 h time period was measured in nmol Fe
mg31 cell protein. There was some inter-experimental varia-
tion in iron levels in both control and Nramp1 positive cells
(see legend to Fig. 2b), but the di¡erences measured were
consistent across experiments.
4. Discussion
The Nramp1 locus has been attributed with many pleio-
tropic e¡ects associated with macrophage antimicrobial activ-
ity [21^25], and the diversity of these e¡ects has confused our
understanding of this protein within the cell. Recently the
Nramp gene family has been implicated with divalent cation
transport and the intimate co-localisation of the Nramp1 pol-
ypeptide with the phagocytosed pathogen [9,10], has provided
clues as to its putative function in antimicrobial activity.
In the present study anti-Nramp1 antiserum recognised
exogenous Nramp1 polypeptides in transfected COS-1 cells,
and native proteins in N11 microglial cells. Two immunoreac-
tive proteins of 45 kDa and 90^100 kDa were identi¢ed and
glycosidase treatment with PNGase F diminished immunore-
activity of the 90^100 kDa species and promoted the appear-
ance of the 45 kDa species. PNGase F cleaves between the
innermost N-acetylglucosamine and asparagine residues of
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Fig. 2. Ectopic expression of Nramp1 cDNA modulates iron accu-
mulation in COS-1 cells. COS-1 cells were transfected using the
pCDNA3 plasmid incorporating (experimental) or lacking (control)
Nramp1 cDNA (G169 allele) as described in legend to Fig. 1. 48 h
post-transfection cells were washed to remove serum and incubated
in Fe3 : nitrilotriacetate (50 WM) under serum-free conditions for a
further 4 h. Cells were harvested, washed extensively in PBS/EDTA
and samples prepared for con¢rmatory Western analysis or iron de-
termination using the ferrozine reagent. a: Expression of Nramp1 in
three independent iron accumulation experiments: experiments 1^3
in lanes 1 and 2; lanes 3 and 4 and lanes 5 and 6 respectively with
vector alone controls (lanes 2, 4 and 6) or with Nramp1 cDNA
(lanes 1, 3 and 5). Positions of 45 kDa and 90^100 kDa polypep-
tides are indicated of the left. b: Cellular iron levels associated with
control (open bars) or Nramp1 transfectant cells (closed bars) from
the samples as shown in (a). Iron levels for each control were arbi-
trarily set at 100%. Actual values (Nramp1/control) (nmol Fe/mg/4
h); Expt 1: 49/64; Expt 2: 17.4/38.5; Expt 3: 12.1/18.5.
P.G.P. Atkinson, C.H. Barton /FEBS Letters 425 (1998) 239^242 241
many N-linked oligosaccharide structures. The glycosylation
is extensive given that the observed molecular weight of 90^
100 kDa on SDS-polyacrylamide gels is some 30^40 kDa
more than that predicted for Nramp1 based on its primary
sequence. The abnormal mobility of the deglycosylated
Nramp1 protein may arise from incomplete denaturation of
the Nramp1 polypeptide, since boiling of macrophage extracts
caused Nramp1 polypeptide aggregation with immunoreactiv-
ity detectable at the stack/resolving gel interface.
A similar pattern of Nramp1 glycosylation was observed
from thioglycolate elicited peritoneal macrophages harvested
from 129sv wild-type mice [19]. Our studies show that the
extensive glycosylation of Nramp1 is not macrophage subtype
speci¢c, although heterogeneity has been reported in
RAW264.7 cell transfectants ([10]; Atkinson and Barton, un-
published) and may represent a strain-speci¢c e¡ect. Such ex-
tensive modi¢cations have been proposed to be required for
correct targeting, and stabilisation of proteins in the hostile
environment found in lysosomes [26].
Here we present evidence demonstrating that Nramp1 can
modulate the accumulation of extracellular iron. Ectopic ex-
pression of wild-type Nramp1 in COS-1 cells was associated
with a reduction in the measured iron content, of nearly 40%
over three experiments. This result is supported by the work
of Zwilling and co-workers [27] who noted a 50% reduction in
the cellular iron content in Q-IFN stimulated macrophages
from Nramp1-resistant mice compared to macrophages from
Nramp1-susceptible mice. It is unclear how Nramp1 modu-
lates total cellular iron levels given that Nramp1 is localised to
intracellular membranes and not the cell surface [11,12].
Nramp1 could be involved in the recycling of iron and one
essential function of phagocytes is to degrade and recycle dead
or dying cells including erythrocytes. By directing iron e¥ux
Nramp1 may participate in the iron salvage pathway in the
resting macrophage [28].
In the present study, iron loading was achieved in the ab-
sence of transferrin, by presenting iron to the cells complexed
with NTA in serum-free media. Iron NTA is unique among
non-physiological iron chelators in that it holds iron in a
soluble form at neutral pH, whereas under mildly acidic con-
ditions free iron salts form hydrolytic polymers from which
the iron is relatively inaccessible. Iron in such low molecular
weight chelates is readily taken up by cells [20] and is thought
to be internalised via melanotransferrin (p97) found on the
surface of many cell types [29]. Iron bound p97 is internalised
by an unde¢ned endocytic process where iron is released and
p97 is recycled back to the cell surface [30]. The transport
protein required to shuttle released iron from p97 (or trans-
ferrin) containing endocytic vesicles into the cytosol is cur-
rently unknown. However, based upon its endosomal loca-
tion, it is tempting to speculate that Nramp1 ful¢ls this
function in professional phagocytes. Therefore, it might be
speculated that in Nramp1 transfected COS-1 cells, internal-
ised iron was more e⁄ciently transported in to the cytosol
from the endosome than in Nramp1 minus controls. Increases
in cytosolic redox active ‘free’ iron would be bu¡ered by fer-
ritin and other chelating agents, but in the short term the
e¥ux of iron from the cell may be expected to increase. In
the absence of Nramp1, the movement of iron from the endo-
some to the cytosol would be slowed, resulting in a build up
of iron in the endosome and reducing iron e¥ux from the cell.
These data form the basis for understanding the role of
Nramp1 directed iron transport in cells and to address its
role in antimicrobial activity.
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